Standard Molecular
Cambridge, US · Founded 2014 · Delaware corporation · 1 known investors
Founders & leadership
NW
Nathaniel WeissNamed on SEC filing
DA
David ArtzNamed on SEC filing
AS
Andrew SmithNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 1 round · 2018
▶$1.4MraisedApr 2018 · 13 investors · BiotechnologyRule 506(b)
▶$1.4MraisedApr 2018 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nathaniel WeissExecutive Officer, Director
- David ArtzDirector
- Andrew SmithDirector
- Offering amount
- $5.7M
- Amount sold
- $1.4M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Standard Molecular's investors?
- Standard Molecular's investors include Evidity Health Capital.
- How much funding has Standard Molecular raised?
- Standard Molecular has disclosed $1.4M raised across 1 round.
- Where is Standard Molecular headquartered?
- Standard Molecular is headquartered in Cambridge, US.